ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapy.

Brian C Gilger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.